Pazia Pharmaceuticals Private Limited

Pazia Pharmaceuticals Private Limited - healthcare in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
CIN U24239RJ2020PTC068280 Incorporated 18 February 2020 ROC Jaipur HQ Jaipur, Rajasthan, India
Active Private Limited Company healthcare MSME · Micro
Data last updated
Revenue · FY 2025
₹1.14 Cr
▲ 820% YoY
Net loss · FY 2025
₹20,961
Net margin -0.2%
EBITDA · FY 2025
₹14,022
EBITDA margin 0.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹9 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Pazia Pharmaceuticals Private Limited

Data last updated:

Pazia Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 18 February 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24239RJ2020PTC068280. Its GSTIN is 08AALCP0639C1ZJ (Rajasthan).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9 Lakh. It is led by directors including Sanprit Kaur and Vibha Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F No 2 Ground Floor C – 115 Savtri Path Bapu Nagar, Jaipur, Rajasthan, India – 302015.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.14 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹20,961 (net margin -0.2%) and EBITDA of ₹14,022 (EBITDA margin 0.1%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years.

Pazia Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0016564).

Company details

CIN U24239RJ2020PTC068280
Registration Number 068280
Incorporation Date 18 February 2020
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0016564
Key People
Sanprit Kaur Director Vibha Sharma Director Kalpit Sharma Director

Recognitions & Rankings of Pazia Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-RJ-17-0016564

Contact details

Pazia Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    F No 2 Ground Floor C – 115 Savtri Path Bapu Nagar, Jaipur, Rajasthan, India – 302015
  • Industry
    Healthcare, Medical & Laboratory Equipment

To see the full contact details of Pazia Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Pazia Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Pazia Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Pazia Pharmaceuticals Private Limited, buy the company report.

Financials of Pazia Pharmaceuticals Private Limited

FY 2025 filings available

Pazia Pharmaceuticals Private Limited reported revenue of ₹1.14 Cr (up 820% YoY) for FY 2025.

Revenue · FY 2025
₹1.14 Cr ▲ 820%
Net loss · FY 2025
₹20,961 margin -0.2%
EBITDA · FY 2025
₹14,022 margin 0.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 820%
3 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 100%
3 years · compounded
▼ 69%

Revenue has grown at a compounded annual rate (CAGR) of 5% over three years, including 820% growth in the latest year. EBITDA rose 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹14,022
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹20,961
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.1%
Net Profit Margin-0.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Pazia Pharmaceuticals Private Limited, buy the company report.

Board of directors of Pazia Pharmaceuticals Private Limited

Pazia Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sanprit Kaur
Also directs: Empowerment Education Private Limited
Director10 Sep 20224 Years 1 MonthsCurrent
Vibha SharmaDirector03 Feb 20224 Years 9 MonthsCurrent
Kalpit Sharma
Also directs: Universal Silica Industries LLP
Director03 Feb 20224 Years 9 MonthsCurrent
View all directors

Auditor

Pazia Pharmaceuticals Private Limited is audited by A J M K & ASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
A J M K & ASSOCIATESFY 2022019318C

Shareholding

The shareholding of Pazia Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Pazia Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Pazia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Pazia Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
08AALCP0639C1ZJRajasthanActive01 Mar 2020

To see the full GST registrations and return filing status of Pazia Pharmaceuticals Private Limited, buy the company report.

Recent activity

Pazia Pharmaceuticals Private Limited has 7 board changes on record since 2022: 3 appointments and 4 cessations. The latest: Kalpit Sharma ceased to be Additional Director on 30 Sep 2022.

AGM
Pazia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Pazia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Ceased
Kalpit Sharma ceased to be Additional Director.
Ceased
Vibha Sharma ceased to be Additional Director.
Appointed
Sanprit Kaur was appointed as Director.
Ceased
Raju Gupta ceased to be Director.
Ceased
Minali Sharma ceased to be Director.
Appointed
Kalpit Sharma was appointed as Director.
Appointed
Vibha Sharma was appointed as Director.
Incorporation
18 Feb 2020
Pazia Pharmaceuticals Private Limited was registered on 18 Feb 2020 with Roc Jaipur & aged 6 years 8 months as per MCA records.

Frequently asked questions

Pazia Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 18 February 2020 (6+ years old) and is registered under CIN U24239RJ2020PTC068280.

Pazia Pharmaceuticals has 3 current directors:

The latest financial statements of Pazia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Pazia Pharmaceuticals is 08AALCP0639C1ZJ, registered in Rajasthan.

The CIN (Corporate Identification Number) of Pazia Pharmaceuticals is U24239RJ2020PTC068280. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Pazia Pharmaceuticals was incorporated on 18 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.

Kalpit Sharma ceased to be Additional Director on 30 Sep 2022. Vibha Sharma ceased to be Additional Director on 30 Sep 2022. Sanprit Kaur was appointed as Director on 10 Sep 2022. Pazia Pharmaceuticals has 7 board changes on record in total.

Yes, Pazia Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0016564).

The registered office of Pazia Pharmaceuticals is at F No 2 Ground Floor C – 115 Savtri Path Bapu Nagar, Jaipur, Rajasthan, India – 302015.

Pazia Pharmaceuticals operates in the healthcare industry, in the medical and laboratory equipment segment.